Nattokinase
7 studies read · 1 answers · 2 sources
Nattokinase shows a faint early signal for normal clot breakdown in humans, while evidence remains too limited and short-term to establish a proven clinical benefit.
What it does
Early findings (1)
-
Lower risk of blood clots · Unclear if it helps
2 trials · 86 people · noticed in 8 weeks
How to take it
Nattokinase suits someone who understands that the clot-support story remains early and is willing to wait for stronger clinical research. It does not suit anyone looking to manage a clotting condition on their own, or anyone taking medicines that affect clotting without clinician guidance. The current human signal is small, short-term, and far from a proven health outcome.1
How much
The only consumer-relevant clot-breakdown signal comes from a small human study using a single 2,000 FU dose. It found short-term changes in fibrin-breakdown markers, not proof that nattokinase prevents harmful clots or delivers a lasting clinical benefit.1 Treat this as an early research protocol, not an established daily target.
When
Research does not establish a best time of day, meal pairing, or long-term schedule for nattokinase. The key human clotting experiment examined changes after a single dose, so claims that you need to take it at bedtime, fasting, or on a particular routine run ahead of the evidence.1 More important than timing: do not add it casually if you use medicines that affect clotting.
Which form
Look for a label that states enzyme activity in FU, rather than relying only on a milligram amount. The human study that drives the clot-breakdown discussion used 2,000 FU, but it does not establish that every product with that number produces the same result.1 Fermented-food natto and isolated nattokinase supplements are not interchangeable research formats.
Who should be careful
Medicines it can clash with
- heparin (unfractionated and related GAGs) major
- fondaparinux major
- enoxaparin major
- dexamethasone moderate
Reported side effects
- cerebellar hemorrhage (intracerebral hemorrhage) severe
- pulmonary haemorrhage
- hemorrhage
- thrombosis
- abdominal discomfort
- stroke (ischemic or hemorrhagic)
How it works
A fermented soybean enzyme has a fascinating clot-cleanup story. The human evidence, however, still fits in the "interesting, not proven" bucket.1
Nattokinase is an enzyme made when Bacillus bacteria ferment soybeans into natto, the sticky Japanese food with a famously strong smell. Supplement makers isolate and concentrate the enzyme, then usually label its activity in fibrinolytic units, or FU.1
Fibrin works like the mesh in a temporary wound patch. Nattokinase appears to nudge fibrin-clearing activity, like loosening that mesh after its repair job ends, and a small human study found short-term shifts in fibrin-breakdown markers after one dose.1 That biological signal is real enough to study, but it does not yet show that the supplement reliably improves meaningful health outcomes.1